uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Rituximab Mabion
Application withdrawn
Human
Details
EMA number
EMEA/H/C/005387
ATC code
L01XC02
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of Non-Hodgkin's lymphoma (NHL), Chronic lymphocytic leukaemia (CLL).
MeSH:
Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis
Group:
Antineoplastic agents
Active substances
rituximab
Marketing Authorisation Holder
Mabion Spolka Akcyjna
MAH
Rituximab Mabion | uMedical